{"id":"W4362657072","doi":"10.1002/cam4.5799","title":"Symptomatic benefit of momelotinib in patients with myelofibrosis: Results from the <scp>SIMPLIFY</scp> phase <scp>III</scp> studies","year":2023,"lang":"en","type":"article","venue":"Cancer Medicine","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Paul's Hospital; University of Toronto; University of British Columbia; University Health Network","funders":"Genentech; Italfarmaco; Cancer Research UK; Galecto; Sierra Oncology; Incyte; CTI Biopharma; Gilead Sciences; Medical Research Council; Celgene; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer","keywords":"Repeated measures design; Medicine; Generalized estimating equation; Myelofibrosis; Clinical trial; Odds ratio; Odds; Quality of life (healthcare); Confidence interval; Longitudinal study; Physical therapy; Logistic regression; Internal medicine; Mathematics; Statistics","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004567863,0.0004454194,0.001065632,0.000330386,0.0001423608,0.0007082073,0.0002307009,0.0003369777,0.0009537389],"category_scores_gemma":[0.004911676,0.0001199941,0.002181119,0.0004564425,0.0002370928,0.000340096,0.0003289504,0.000560978,0.0001169889],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004227611,"about_ca_system_score_gemma":0.0005529459,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006028561,"about_ca_topic_score_gemma":0.002041734,"domain_scores_codex":[0.9991129,0.0004062738,0.0001437913,0.00009637795,0.0001821543,0.00005858063],"domain_scores_gemma":[0.9958968,0.001740328,0.001369169,0.000225767,0.000522888,0.0002450444],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1271762,0.002146771,0.1720366,0.0108455,0.02511682,0.000281391,0.0007102134,0.00304903,0.01178522,0.0005045802,0.007650854,0.6386968],"study_design_scores_gemma":[0.03306325,0.05873607,0.8344417,0.002668126,0.03803258,0.001266852,0.0004540119,0.002081202,0.004451823,0.0007575006,0.02393326,0.000113589],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8425215,0.1497083,0.0005228718,0.001229526,0.00008437225,0.0003900398,0.001860284,0.00004272623,0.003640463],"genre_scores_gemma":[0.9745693,0.021285,0.0006945493,0.0007096544,0.0002245252,0.0001503878,0.002026019,0.00001015995,0.0003304589],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004567863,"threshold_uncertainty_score":0.02415746,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03805187361331621,"score_gpt":0.3312531560186777,"score_spread":0.2932012824053615,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}